SAM
JAZZ icon

Smartleaf Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Smartleaf Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.1K Hold
219
– – ﹤0.01% 1494
2026
Q1 		$40.1K Sell
219
-6
-3% -$1.05K ﹤0.01% 1578
2025
Q4 		$38.4K Buy
225
+53
+31% +$8.13K ﹤0.01% 1680
2025
Q3 		$22.2K Buy
172
+95
+123% +$11.4K ﹤0.01% 1777
2025
Q2 		$8.23K Sell
77
-47
-38% -$5.11K ﹤0.01% 1893
2025
Q1 		$15.2K Buy
124
+10
+9% +$1.3K ﹤0.01% 1745
2024
Q4 		$14K Buy
114
+56
+97% +$6.6K ﹤0.01% 1847
2024
Q3 		$6.43K Buy
58
+45
+346% +$4.93K ﹤0.01% 2002
2024
Q2 		$1.39K Buy
13
+4
+44% +$440 ﹤0.01% 2336
2024
Q1 		$1.08K Buy
+9
New +$1.1K ﹤0.01% 1610

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Smartleaf Asset Management's JAZZ Position: Q2 2026 in Review

Smartleaf Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 219 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

Smartleaf Asset Management first reported a position in JAZZ in Q1 2024 and has held it in 10 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Smartleaf Asset Management held 219 shares of Jazz Pharmaceuticals worth $52.1K as of Q2 2026.
  • Smartleaf Asset Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1494 holding.
  • Smartleaf Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.